Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Lippman

Showing results (71-80 of 352) with videos related to

Pageof 36
Sort By:
Journal of the National Cancer Institute|February 24, 2001
Adjuvant therapy for all patients with breast cancer?M E Lippman, D F Hayes
Journal of Receptor Research|January 1, 1981
Effects of temperature, nucleotides and sodium molybdate on activation and DNA binding of estrogen, glucocorticoid, progesterone and androgen receptors in MCF-7 human cancer cellsM T Chong, M E Lippman
Lancet (London, England)|May 26, 1973
Drug combinations in malignant diseaseM E Lippman, E B Thompson
European Journal of Cancer & Clinical Oncology|July 1, 1987
Stimulation of breast cancer with estrogens: how much clinical value?N E Davidson, M E Lippman
The New England Journal of Medicine|May 3, 1979
Hormone receptors in breast cancer and response to chemotherapyM E Lippman, J C Allegra
Oncogene|February 10, 2015
Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progressionE T Goka, M E Lippman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Tamoxifen flare in advanced endometrial carcinomaB J Brooks, M E Lippman
Journal of Steroid Biochemistry|January 1, 1989
Mechanisms of normal and malignant breast epithelial growth regulationM E Lippman, R B Dickson
Cancer Treatment Reports|April 1, 1984
Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancerR M Levine, M E Lippman
Hematology/Oncology Clinics of North America|February 1, 1994
Overview of the biologic markers of breast cancerK Porter-Jordan, M E Lippman
Pageof 36

Showing results (71-80 of 352) with videos related to

Sort By:
Pageof 36
Journal of the National Cancer Institute|February 24, 2001
Adjuvant therapy for all patients with breast cancer?M E Lippman, D F Hayes
Journal of Receptor Research|January 1, 1981
Effects of temperature, nucleotides and sodium molybdate on activation and DNA binding of estrogen, glucocorticoid, progesterone and androgen receptors in MCF-7 human cancer cellsM T Chong, M E Lippman
Lancet (London, England)|May 26, 1973
Drug combinations in malignant diseaseM E Lippman, E B Thompson
European Journal of Cancer & Clinical Oncology|July 1, 1987
Stimulation of breast cancer with estrogens: how much clinical value?N E Davidson, M E Lippman
The New England Journal of Medicine|May 3, 1979
Hormone receptors in breast cancer and response to chemotherapyM E Lippman, J C Allegra
Oncogene|February 10, 2015
Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progressionE T Goka, M E Lippman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Tamoxifen flare in advanced endometrial carcinomaB J Brooks, M E Lippman
Journal of Steroid Biochemistry|January 1, 1989
Mechanisms of normal and malignant breast epithelial growth regulationM E Lippman, R B Dickson
Cancer Treatment Reports|April 1, 1984
Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancerR M Levine, M E Lippman
Hematology/Oncology Clinics of North America|February 1, 1994
Overview of the biologic markers of breast cancerK Porter-Jordan, M E Lippman
Pageof 36